ARCHIVES

Tarceva Reaches Endpoint Early: Longer PFS Than Chemo Alone

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Scientific Opportunity Should Guide Fund Allocation, House Says

August 4, 1995

Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System

March 5, 1999

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

Clinical Trials Approved By NCI Last Month Are Listed

August 29, 2003

Funding Opportunities.

May 31, 2002

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981